Literature DB >> 33466800

GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.

Marion Laudette1, Karina Formoso1, Frank Lezoualc'h1.   

Abstract

β-adrenergic receptors (β-ARs) play a major role in the physiological regulation of cardiac function through signaling routes tightly controlled by G protein-coupled receptor kinases (GRKs). Although the acute stimulation of β-ARs and the subsequent production of cyclic AMP (cAMP) have beneficial effects on cardiac function, chronic stimulation of β-ARs as observed under sympathetic overdrive promotes the development of pathological cardiac remodeling and heart failure (HF), a leading cause of mortality worldwide. This is accompanied by an alteration in cAMP compartmentalization and the activation of the exchange protein directly activated by cAMP 1 (Epac1) signaling. Among downstream signals of β-ARs, compelling evidence indicates that GRK2, GRK5, and Epac1 represent attractive therapeutic targets for cardiac disease. Here, we summarize the pathophysiological roles of GRK2, GRK5, and Epac1 in the heart. We focus on their signalosome and describe how under pathological settings, these proteins can cross-talk and are part of scaffolded nodal signaling systems that contribute to a decreased cardiac function and HF development.

Entities:  

Keywords:  Epac1; G protein-coupled receptor kinases; cAMP; signaling; β-adrenergic receptors

Year:  2021        PMID: 33466800      PMCID: PMC7830799          DOI: 10.3390/cells10010154

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  127 in total

1.  Usefulness of Exchanged Protein Directly Activated by cAMP (Epac)1-Inhibiting Therapy for Prevention of Atrial and Ventricular Arrhythmias in Mice.

Authors:  Rajesh Prajapati; Takayuki Fujita; Kenji Suita; Takashi Nakamura; Wenqian Cai; Yuko Hidaka; Masanari Umemura; Utako Yokoyama; Björn C Knollmann; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  Circ J       Date:  2018-12-06       Impact factor: 2.993

Review 2.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Calcium/Calmodulin-Dependent Protein Kinase II Activity Persists During Chronic β-Adrenoceptor Blockade in Experimental and Human Heart Failure.

Authors:  Matthias Dewenter; Stefan Neef; Christiane Vettel; Simon Lämmle; Christina Beushausen; Laura C Zelarayan; Sylvia Katz; Albert von der Lieth; Stefanie Meyer-Roxlau; Silvio Weber; Thomas Wieland; Samuel Sossalla; Johannes Backs; Joan H Brown; Lars S Maier; Ali El-Armouche
Journal:  Circ Heart Fail       Date:  2017-05       Impact factor: 8.790

Review 4.  Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Rui-Ping Xiao; Weizhong Zhu
Journal:  Br J Pharmacol       Date:  2014-12-17       Impact factor: 8.739

5.  A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation.

Authors:  Geng-Xian Shi; Holger Rehmann; Douglas A Andres
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

6.  Exchange-protein activated by cAMP (EPAC) regulates L-type calcium channel in atrial fibrillation of heart failure model.

Authors:  M-X Zhang; J-K Zheng; W-W Wang; F-Q Kong; X-X Wu; J-K Jiang; J-X Pan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-03       Impact factor: 3.507

7.  The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).

Authors:  Delphine Courilleau; Pascal Bouyssou; Rodolphe Fischmeister; Frank Lezoualc'h; Jean-Paul Blondeau
Journal:  Biochem Biophys Res Commun       Date:  2013-10-04       Impact factor: 3.575

Review 8.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

9.  Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator.

Authors:  Bas Ponsioen; Jun Zhao; Jurgen Riedl; Fried Zwartkruis; Gerard van der Krogt; Manuela Zaccolo; Wouter H Moolenaar; Johannes L Bos; Kees Jalink
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

10.  Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.

Authors:  Petronila Penela; Javier Inserte; Paula Ramos; Antonio Rodriguez-Sinovas; David Garcia-Dorado; Federico Mayor
Journal:  EBioMedicine       Date:  2019-10-05       Impact factor: 8.143

View more
  1 in total

Review 1.  G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Authors:  Nan Li; Shan Shan; Xiu-Qin Li; Ting-Ting Chen; Meng Qi; Sheng-Nan Zhang; Zi-Ying Wang; Ling-Ling Zhang; Wei Wei; Wu-Yi Sun
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.